Recent Finacing
Recent Raise
TECLens is a clinical-stage ophthalmic device company developing qCXL™ and the CXLens® delivery system that reshapes corneas using patterned UV light, onboard ultrasound feedback, and patient-specific biomechanics-based treatment plans.
